GT Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
GT Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2022 to Q4 2022.
  • GT Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 31, 2022 was $91K.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $91K Dec 31, 2022 10-K 2023-03-30
Q3 2022 $2M Sep 30, 2022 10-Q 2022-10-31
Q2 2022 $66M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $65M Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.